Abstract
BackgroundTakayasu's arteritis (TAK) has a prolonged chronic course and requires long-term immunosuppressive treatment with different results. Tumor necrosis factor (TNF) alpha is a promising target for treatment in patients with...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
